Clinical advantages and pleiotropic effects of Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
Archives of Pharmaceutical Sciences Ain Shams University · 07.11.2026 · 0-0
DOI: 10.21608/aps.2026.490290.1264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Pharmaceutical Sciences Ain Shams University, online erschienen am 07.11.2026. Verfasst von Omnia Hassan Bayoumi und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bayoumi, O. H., Wahdan, S. A., & Mantawy, E. M. (2026). Clinical advantages and pleiotropic effects of Sodium-glucose cotransporter-2 inhibitors (SGLT2i). Archives of Pharmaceutical Sciences Ain Shams University, 0(0), 0-0. https://doi.org/10.21608/aps.2026.490290.1264
Vancouver
Bayoumi OH, Wahdan SA, Mantawy EM. Clinical advantages and pleiotropic effects of Sodium-glucose cotransporter-2 inhibitors (SGLT2i). Archives of Pharmaceutical Sciences Ain Shams University. 2026;0(0):0-0. doi:10.21608/aps.2026.490290.1264
BibTeX
@article{Bayoumi2026,
author = {Bayoumi, Omnia Hassan and Wahdan, Sara A. and Mantawy, Eman M.},
title = {Clinical advantages and pleiotropic effects of Sodium-glucose cotransporter-2 inhibitors (SGLT2i)},
journal = {Archives of Pharmaceutical Sciences Ain Shams University},
year = {2026},
volume = {0},
number = {0},
pages = {0--0},
doi = {10.21608/aps.2026.490290.1264}
}
EUVIMED